| 13 |
Wolk K, Witte E, Wallace E, et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis[J]. Eur J Immunol,2006,36(5):1309-1323.
|
| 14 |
Kagami S, Rizzo HL, Lee JJ, et al. Circulating Th17, Th22, and Th1 cells are increased in psoriasis[J]. J Invest Dermatol,2010,130(5):1373-1383.
|
| 15 |
Tohyama M, Hanakawa Y, Shirakata Y, et al. IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression[J]. Eur J Immunol,2009,39(10):2779-2788.
|
| 16 |
Witte E, Witte K, Warszawska K, et al. Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection[J]. Cytokine Growth Factor Rev,2010,21(5):365-379.
|
| 17 |
Veldhoen M, Hirota K, Christensen J, et al. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells[J]. J Exp Med,2009,206(1):43-49.
|
| 18 |
Yao S, Huang D, Chen CY, et al. Differentiation, distribution and gammadelta T cell-driven regulation of IL-22-producing T cells in tuberculosis[J]. PLoS Pathog,2010,6(2):e1000789.
|
| 19 |
Qiao D, Yang BY, Li L, et al. ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection[J]. Scand J Immunol,2011,73(4):330-337.
|
| 20 |
Kim CJ, Nazli A, Rojas OL, et al. A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis[J]. Mucosal Immunol,2012,5(6):670-680.
|
| 21 |
Liu T, Peng L, Yu P, et al. Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer[J]. J Clin Immunol,2012,32(6):1332-1339.
|
| 22 |
Jiang R, Tan Z, Deng L, et al. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3[J]. Hepatology,2011,54(3):900-909.
|
| 23 |
Park O, Wang H, Weng H, et al. In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression[J]. Hepatology,2011,54(1):252-261.
|
| 24 |
Zhang W, Chen Y, Wei H, et al. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts[J]. Clin Cancer Res,2008,14(20):6432-6439.
|
| 25 |
Weber GF, Gaertner FC, Erl W, et al. IL-22-mediated tumor growth reduction correlates with inhibition of ERK1/2 and AKT phosphorylation and induction of cell cycle arrest in the G2-M phase[J]. J Immunol,2006,177 (11):8266-8272.
|
| 26 |
Radaeva S, Sun R, Pan HN, et al. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation[J]. Hepatology,2004,39(5):1332-1342.
|
| 27 |
Brand S, Dambacher J, Beigel F, et al. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro[J]. Am J Physiol Gastrointest Liver physiol,2007,292(4):G1019-G1028.
|
| 28 |
Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells[J]. Hepatology,2004,39(6):1477-1487.
|
| 1 |
Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation[J]. Immunity,2008,28(4):454-467.
|
| 2 |
Duhen T, Geiger R, Jarrossay D, et al. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells[J]. Nat Immunol,2009,10(8):857-863.
|
| 3 |
Eyerich S, Eyerich K, Pennino D, et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling[J]. J Clin Invest,2009,119(12):3573-3585.
|
| 4 |
Trifari S, Kaplan CD, Tran EH, et al. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells[J]. Nat Immunol,2009,10(8):864-871.
|
| 5 |
Fujita H, Nograles KE, Kikuchi T, et al. Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production[J]. Proc Natl Acad Sci USA,2009,106(51):21795-21800.
|
| 6 |
Zhang L, Li YG, Li YH, et al. Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis[J]. PloS one,2012,7(4):e31000.
|
| 7 |
Veldhoen M, Hirota K, Westendorf AM, et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins[J]. Nature,2008,453(7191):106-109.
|
| 8 |
Dumoutier L, Louahed J, Renauld JC. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9[J]. J Immunol,2000,164(4):1814-1819.
|
| 9 |
Lejeune D, Dumoutier L, Constantinescu S, et al. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10[J]. J Biol Chem,2002,277(37):33676-33682.
|
| 10 |
Andoh A, Zhang Z, Inatomi O, et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts[J]. Gastroenterology,2005,129(3):969-984.
|
| 11 |
Heydenreich B, Bellinghausen I, Koenig B, et al. Gram-positive bacteria on grass pollen exhibit adjuvant activity inducing inflammatory T cell responses[J]. Clin Exp Allergy,2012,42(1):76-84.
|
| 12 |
Boniface K, Guignouard E, Pedretti N, et al. A role for T cell-derived interleukin 22 in psoriatic skin inflammation[J]. Clin Exp Immunol,2007,150(3):407-415.
|
| 29 |
Xiang X, Gui H, King NJ, et al. IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver[J]. Immunol Cell Biol,2012,90(6):611-619.
|
| 30 |
Zhang Y, Cobleigh MA, Lian JQ, et al. A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus[J]. Gastroenterology,2011,141(5):1897-1906.
|
| 31 |
Xing WW, Zou MJ, Liu S, et al. Interleukin-22 protects against acute alcohol-induced hepatotoxicity in mice[J]. Biosci Biotechnol Biochem,2011,75(7):1290-1294.
|
| 32 |
Sabat R, Ouyang W, Wolk K. Therapeutic opportunities of the IL-22-IL-22R1 system[J]. Nat Rev Drug Discov,2014,13(1):21-38.
|